1.54
price down icon0.65%   -0.01
 
loading
Schlusskurs vom Vortag:
$1.55
Offen:
$1.5407
24-Stunden-Volumen:
1,131
Relative Volume:
0.03
Marktkapitalisierung:
$20.22M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-13.59M
KGV:
-1.4259
EPS:
-1.08
Netto-Cashflow:
$-19.79M
1W Leistung:
+2.67%
1M Leistung:
-16.76%
6M Leistung:
-56.13%
1J Leistung:
-74.33%
1-Tages-Spanne:
Value
$1.54
$1.55
1-Wochen-Bereich:
Value
$1.48
$1.60
52-Wochen-Spanne:
Value
$1.43
$6.0199

Calcimedica Inc Stock (CALC) Company Profile

Name
Firmenname
Calcimedica Inc
Name
Telefon
858-952-5500
Name
Adresse
505 COAST BOULEVARD SOUTH, LA JOLLA
Name
Mitarbeiter
14
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
CALC's Discussions on Twitter

Vergleichen Sie CALC mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CALC
Calcimedica Inc
1.54 20.22M 0 -13.59M -19.79M -1.08
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
501.31 126.96B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.67 65.06B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ARGX
Argen X Se Adr
650.80 37.54B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
261.49 32.56B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
257.10 26.40B 3.81B -644.79M -669.77M -6.24

Calcimedica Inc Aktie (CALC) Neueste Nachrichten

pulisher
Apr 28, 2025

Bristol-Myers Squibb (NYSE:BMY) vs. CalciMedica (NASDAQ:CALC) Critical Review - Defense World

Apr 28, 2025
pulisher
Apr 24, 2025

CalciMedica (NASDAQ:CALC) Shares Up 0.7% – Here’s Why - Defense World

Apr 24, 2025
pulisher
Apr 17, 2025

CalciMedica's Breakthrough Research Takes Center Stage at Two Elite Medical Conferences - Stock Titan

Apr 17, 2025
pulisher
Apr 03, 2025

Analysts Offer Predictions for CalciMedica Q4 Earnings - Defense World

Apr 03, 2025
pulisher
Apr 02, 2025

CalciMedica Inc. (CALC) Moves to Buy: Rationale Behind the Upgrade - Yahoo Finance

Apr 02, 2025
pulisher
Apr 02, 2025

Corient Private Wealth LLC Buys New Shares in CalciMedica, Inc. (NASDAQ:CALC) - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

CalciMedica (NASDAQ:CALC) Receives “Buy” Rating from HC Wainwright - Defense World

Apr 02, 2025
pulisher
Apr 01, 2025

Graybug Vision stock hits 52-week low at $1.81 - Investing.com India

Apr 01, 2025
pulisher
Apr 01, 2025

Graybug Vision stock hits 52-week low at $1.81 By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Apr 01, 2025

H.C. Wainwright maintains $16 target on CalciMedica stock - Investing.com Australia

Apr 01, 2025
pulisher
Apr 01, 2025

CalciMedica’s Strong Financial Position and Promising Clinical Pipeline Justify Buy Rating - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

CalciMedica to Participate in the Jones Healthcare and Technology Innovation Conference - PR Newswire

Apr 01, 2025
pulisher
Mar 27, 2025

CalciMedica says cash sufficient to fund operating plan into mid-2026 - TipRanks

Mar 27, 2025
pulisher
Mar 27, 2025

CALCIMEDICA Earnings Results: $CALC Reports Quarterly Earnings - Nasdaq

Mar 27, 2025
pulisher
Mar 27, 2025

CalciMedica Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 27, 2025
pulisher
Mar 27, 2025

CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates - Citizen Tribune

Mar 27, 2025
pulisher
Mar 27, 2025

Calcimedica Reports 2024 Financial Results And Provides Clinical & Corporate Updates - MarketScreener

Mar 27, 2025
pulisher
Mar 25, 2025

CalciMedica (CALC) to Release Earnings on Thursday - The AM Reporter

Mar 25, 2025
pulisher
Mar 24, 2025

CalciMedica Inc expected to post a loss of 35 cents a shareEarnings Preview - TradingView

Mar 24, 2025
pulisher
Mar 20, 2025

Atria Investments Inc Buys 7,509 Shares of CalciMedica, Inc. (NASDAQ:CALC) - Defense World

Mar 20, 2025
pulisher
Mar 20, 2025

CalciMedica (CALC) Expected to Announce Quarterly Earnings on Thursday - Defense World

Mar 20, 2025
pulisher
Mar 13, 2025

Graybug Vision stock hits 52-week low at $1.83 amid challenges - Investing.com

Mar 13, 2025
pulisher
Mar 13, 2025

Head to Head Survey: Rani Therapeutics (NASDAQ:RANI) vs. CalciMedica (NASDAQ:CALC) - The AM Reporter

Mar 13, 2025
pulisher
Mar 11, 2025

Rani Therapeutics (NASDAQ:RANI) versus CalciMedica (NASDAQ:CALC) Financial Contrast - Defense World

Mar 11, 2025
pulisher
Mar 07, 2025

Promising Phase 2 Results and Market Potential Drive Buy Rating for CalciMedica’s Auxora - TipRanks

Mar 07, 2025
pulisher
Mar 06, 2025

Short Interest in CalciMedica, Inc. (NASDAQ:CALC) Increases By 35.0% - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

Latham & Watkins Advises CalciMedica in Secured Growth Financing - Latham & Watkins LLP

Mar 05, 2025
pulisher
Mar 05, 2025

CalciMedica secures $32.5 million credit facility By Investing.com - Investing.com Canada

Mar 05, 2025
pulisher
Mar 05, 2025

CalciMedica secures credit facility for up to $32.5M - MSN

Mar 05, 2025
pulisher
Mar 05, 2025

CalciMedica Secures Credit Facility For Up To $32.5 Million -March 05, 2025 at 07:44 am EST - Marketscreener.com

Mar 05, 2025
pulisher
Mar 05, 2025

CalciMedica secures $32.5 million credit facility - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

CalciMedica Secures Credit Facility for Up to $32.5 Million - Finansavisen

Mar 05, 2025
pulisher
Mar 05, 2025

CalciMedica (NASDAQ:CALC) Given “Buy” Rating at HC Wainwright - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

Graybug Vision stock hits 52-week low at $1.95 amid challenges - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

CalciMedica reports reduced mortality in AKI trial with Auxora - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

CalciMedica Highlights Auxora’s Potential in COVID-19 Treatment - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

CalciMedica reports reduced mortality in AKI trial with Auxora By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

CalciMedica’s Auxora shows mortality reduction in COVID-19 pneumonia trial - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

CalciMedica Presents AKI Data from a Post-Hoc Analysis of the Phase 2 CARDEA trial of Auxora™ in Severe COVID-19 Pneumonia at the 30th International AKI & CRRT Conference - PR Newswire

Mar 04, 2025
pulisher
Mar 04, 2025

CalciMedica, Inc. (CALC): Among Penny Stocks with Insider Buying in 2025 - Insider Monkey

Mar 04, 2025
pulisher
Mar 03, 2025

12 Penny Stocks with Insider Buying in 2025 - Insider Monkey

Mar 03, 2025
pulisher
Feb 19, 2025

CalciMedica Announces Upcoming Plenary Presentation at the 30th International AKI & CRRT Conference - PR Newswire

Feb 19, 2025
pulisher
Feb 03, 2025

CalciMedica to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Longview News-Journal

Feb 03, 2025
pulisher
Jan 15, 2025

CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors - Victoria Advocate

Jan 15, 2025
pulisher
Jan 14, 2025

CalciMedica announces board changes By Investing.com - Investing.com Australia

Jan 14, 2025
pulisher
Jan 14, 2025

CalciMedica appoints new director amid clinical trials By Investing.com - Investing.com Nigeria

Jan 14, 2025
pulisher
Jan 14, 2025

CalciMedica announces board changes - Investing.com

Jan 14, 2025
pulisher
Jan 14, 2025

CalciMedica appoints new director amid clinical trials - Investing.com

Jan 14, 2025
pulisher
Jan 14, 2025

CalciMedica Announces Board Changes and New Appointment - TipRanks

Jan 14, 2025
pulisher
Jan 14, 2025

CalciMedica, Inc. (NASDAQ:CALC) Shares Acquired by Geode Capital Management LLC - Defense World

Jan 14, 2025
pulisher
Dec 19, 2024

CalciMedica to Host a Call to Review Full Data Set, including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) - The Eastern Progress Online

Dec 19, 2024

Finanzdaten der Calcimedica Inc-Aktie (CALC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$72.51
price down icon 0.01%
$21.58
price up icon 2.96%
$32.56
price up icon 0.06%
$29.24
price up icon 18.78%
$105.61
price up icon 3.06%
biotechnology ONC
$256.40
price up icon 0.63%
Kapitalisierung:     |  Volumen (24h):